Avanos reports Q1 adjusted EPS 22c, consensus 21c

Reports Q1 revenue $166.1M, consensus $162.9M. “As we begin the second year of our three-year transformation initiative, we are pleased with our first quarter results,” said Joe Woody, Avanos’s CEO. Woody added, “We continue to make progress on our long-term margin expansion targets, are delivering on our Digestive Health growth objectives and have made improvements in our Pain Management and Recovery franchise that will support our mid-single digit growth in the back half of the year.”